MED AD NEWS
JANUARY, 2002
Most-Recognized Pain and Inflammation Brands
Market Research Company
2,000 physicians and pharmacists from North America and
Europe were surveyed by Brand Institute, Inc., a biotechnology branding,
pharmaceutical branding, and consumer branding consultancy firm, to determine
the most-recognizable pharmaceutical brands in the pain and inflammation
category. According to results from
Brand Institute’s Brandpoll.com, the most-recognized pain and
inflammation drug to North American health-care professionals is Motrin
(ibuprofen). Motrin is an over-the-counter drug that is indicated for the
temporary relief of headache, muscular aches, the minor pain of arthritis,
toothache, backache, minor aches and pains associated with the common cold, the
pain of menstrual cramps, and for reduction of fever. The product is marketed
in the United States by McNell Consumer Healthcare, a subsidiary of
Johnson & Johnson.
Market Research Company
In Europe, the most-recognized pharmaceutical brand name for pain and inflammation among health-care professionals is Voltaren (diclofenac). This pharma product is indicated for the acute and chronic treatment of signs and symptoms of osteoarthritis and the acute and chronic treatment of signs and symptoms of rheumatoid arthritis. Voltaren is marketed by Novartis Pharma AG (www.novartispharma.com). The product generated sales of $801.6 million in 2000.
The Brandpoll.com sample consisted of physicians of various
specialties and hospital and retail pharmacists surveyed by Brand Institute
(www.brandinstitute.com), a consumer, biotech and pharmaceutical brand name and
identity consultancy. Brandpoll.com is a
marketing tool that assists clients in monitoring the competitive marketplace
and in identifying the potential strengths and weaknesses of their brand names.
Market Research Company
